These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7025022)

  • 21. Dosage and method of administration of drugs in childhood.
    Robinson GC; Williams VS
    Practitioner; 1970 Jan; 204(219):5-13. PubMed ID: 5411157
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug delivery systems.
    Davis SS; Illum L
    Practitioner; 1983 Oct; 227(1384):1537-43. PubMed ID: 6634624
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peroral depot -drug forms].
    Soliva M; Speiser P
    Pharm Acta Helv; 1966 Mar; 41(3):176-89. PubMed ID: 5982959
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug vectorization or how to modulate tissular and cellular distribution of biologically active compounds].
    Couvreur P
    Ann Pharm Fr; 2001 Jul; 59(4):232-8. PubMed ID: 11468577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The carrier potential of liposomes in biology and medicine (second of two parts).
    Gregoriadis G
    N Engl J Med; 1976 Sep; 295(14):765-70. PubMed ID: 785256
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biopharmacy and pharmacokinetics].
    Janků I
    Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
    [No Abstract]   [Full Text] [Related]  

  • 28. [Statement on prescription drugs: nurses often have problems with strength conversion].
    Christensen PR
    Sygeplejersken; 1981 Feb; 81(6):12. PubMed ID: 6908279
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biological availability of drugs].
    Holovkin VO
    Farm Zh; 1979; (2):20-5. PubMed ID: 456507
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
    Bhatt PP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transdermal therapeutics].
    Touitou E; Menczel E
    Harefuah; 1986 Apr; 110(7):356-9. PubMed ID: 3089890
    [No Abstract]   [Full Text] [Related]  

  • 32. [Simulated passive absorption of active principles on artificial lipid membranes].
    Robert H; Guyot-Hermann AM; Lefebvre C
    Lille Med; 1980; 25(6):311-7. PubMed ID: 7401903
    [No Abstract]   [Full Text] [Related]  

  • 33. Innovations in drug delivery.
    Conrad KA
    Postgrad Med; 1984 Oct; 76(5):71-3, 75-9. PubMed ID: 6483697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribing and drug use in general dental practice. 1. Principles.
    Duxbury AJ; Leach FN
    Dent Update; 1983 Oct; 10(9):567-9, 572, 574-7. PubMed ID: 6581105
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.
    Letchford K; Burt H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):259-69. PubMed ID: 17196803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives in cancer research. Increased selectivity of drugs by linking to carriers.
    Trouet A
    Eur J Cancer (1965); 1978 Feb; 14(2):105-11. PubMed ID: 342253
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.
    Wagner JG
    Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857
    [No Abstract]   [Full Text] [Related]  

  • 39. The physical and chemical problems inherent in the formulation of dosage forms for new pharmaceuticals. II.
    Macek TJ
    Am J Pharm Sci Support Public Health; 1966; 138(1):22-41. PubMed ID: 5951741
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drugs, drug forms and intake conditions: pharmacokinetic selection criteria and consequences for dosage recommendations].
    Ahr G
    Pharm Unserer Zeit; 1996 Jul; 25(4):197-8. PubMed ID: 8927636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.